MedTrace Logo

Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)

NCT01054690 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 511

Last updated 2010-01-22

No results posted yet for this study

Summary

This study is a single blinded (Outcome Assessors), multicenter randomized controlled study designed to investigate if a silver alloyed urinary catheter with antibacterial properties can reduce the incidence of catheter acquired urinary tract infections in patients undergoing elective surgery. Patients requiring urinary catheterization will be randomized into two groups and receive either the silver alloyed catheter (test) or a silicone catheter (control).

Conditions

Interventions

DEVICE

Bactiguard Infection Protection (BIP) Cathter.

DEVICE

Silicone Urinary Catheter

Sponsors & Collaborators

  • Bactiguard AB, Sweden

    collaborator UNKNOWN

  • Region Skane

    lead OTHER

Principal Investigators

  • Karin Stenzelius, PhD Nurse · Department Urology, University Hospital in Lund, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01054690 on ClinicalTrials.gov